Life Sciences Oral Disease Therapies sector
Strategic acquirers, private equity (buyout funds and growth funds) firms, and valuation benchmarks for Life Sciences Oral Disease Therapies
1.1 - About Life Sciences Oral Disease Therapies sector
Companies in the Life Sciences Oral Disease Therapies category develop and commercialize therapeutics, biomaterials, diagnostics, and devices that prevent, detect, and treat dental disorders. Their offerings address caries, periodontal disease, malocclusion, temporomandibular joint disorders, and xerostomia, helping providers improve outcomes, preserve dentition, and reduce invasive procedures. By combining clinical evidence with chairside usability, these vendors enable scalable, cost-effective oral health interventions across private practices and specialty clinics.
Typical capabilities span prescription anti-caries agents such as fluoride varnishes and silver diamine fluoride; host-modulation and localized antimicrobials for periodontitis; regenerative biomaterials including bone grafts, collagen membranes, and enamel/dentin remineralization formulations; implant systems with bioactive surfaces; clear aligners and occlusal correction appliances; TMJ and bruxism devices; as well as saliva-based diagnostics, chairside molecular tests, and caries detection adjuncts integrated into evidence-based treatment pathways.
Primary customer segments include general dental practices, periodontics and orthodontic specialties, and dental service organizations. These solutions drive measurable outcomes such as higher treatment efficacy and implant success, reduced chair time and retreatment rates, improved patient adherence and comfort, and more predictable reimbursement and clinical documentation. Vendors also support standardized protocols, enabling consistent quality of care across multi-site networks and academic or hospital-based oral health programs.
2. Buyers in the Life Sciences Oral Disease Therapies sector
2.1 Top strategic acquirers of Life Sciences Oral Disease Therapies companies
Align Technology
- Description: Provider of digital orthodontic solutions delivering the Invisalign clear aligner system, iTero intra-oral scanners and associated 3D treatment-planning software, enabling dental professionals worldwide to plan, customize and monitor orthodontic and restorative treatments for millions of patients.
- Key Products:
- Invisalign System: Clear, removable aligners engineered with SmartForce features to correct simple to complex malocclusions, giving patients aesthetic, comfortable tooth-straightening managed by trained doctors
- iTero Element Intraoral Scanners: High-precision, full-color imaging devices offering rapid scan speed, accuracy and visualization to support restorative and orthodontic workflows and seamless Invisalign case submission
- Vivera Retainers: Subscription retainer program delivering fresh, durable clear retainers every three months to maintain post-treatment tooth position with superior strength material
- ClinCheck Pro 6.0: Cloud-based digital treatment-planning software that lets doctors access robust 3D tools and In-Face visualization anytime, enabling precise, personalized aligner setups and progress tracking.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
2.2 - Strategic buyer groups for Life Sciences Oral Disease Therapies sector
M&A buyer group 1: Prosthodontics
Keystone Dental
- Type: N/A
- Employees: ●●●●●
- Description: Provider of end-to-end tooth replacement solutions for dental practitioners, offering innovative dental implant systems, biomaterials, prosthetic solutions and digital dentistry workflows. Headquartered in Irvine, California, the global commercial-stage medical technology company markets products such as its Genesis Active, Molaris and Prima Plus implant systems, Paltop value implants, DYNA biomaterials and Nexus digital solutions worldwide.
- Key Products:
- Genesis Active Implant System: integrated surgical and restorative dental implant platform combining multiple implant technologies, enabling efficient placement and restoration procedures for dental professionals
- Nexus Connect: machine-learning powered software that processes intraoral scanner implant scans, detects gauges with 3D computer vision and instantly produces accurate positional data for prosthetic design
- Nexus iOS Scan Gauge: allows dentists to capture direct full-arch implant scans with intraoral scanners, replacing manual impressions with faster, predictable and passive-fit digital workflow
- Osteon prosthetic solutions portfolio: comprehensive implant-based prosthetics and digital workflows, including Nexus iOS, supporting efficient restoration of fully edentulous patients.
Buyer group 2: ████████ ████████
●● companiesBuyer group 3: ████████ ████████
●● companies3. Investors and private equity firms in Life Sciences Oral Disease Therapies sector
3.1 - Buyout funds in the Life Sciences Oral Disease Therapies sector
2.2 - Strategic buyer groups for Life Sciences Oral Disease Therapies sector
4 - Top valuation comps for Life Sciences Oral Disease Therapies companies
4.2 - Public trading comparable groups for Life Sciences Oral Disease Therapies sector
Valuation benchmark group 1: Small-Molecule Pharmaceutical Manufacturing Companies
Eli Lilly
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of innovative medicines and biotechnology solutions aimed at improving global health. Utilizes advanced scientific research and development to create treatments for various medical conditions, enhancing quality of life and addressing unmet clinical needs in diverse healthcare areas.
- Key Products:
- Insulin Access Programs: Solutions to provide accessible insulin treatments for diabetes management.
- Cancer Treatments: Medicines targeted at oncology to improve patient outcomes.
- Cardiovascular Treatments: Innovative treatments for heart-related conditions.
- Immunology: Solutions addressing autoimmune diseases and enhancing immune system health.
- Neuroscience: Medications to treat neurological disorders including Alzheimer's and schizophrenia.